The Benefits of Docetaxel Plus Cisplatin and 5-Fluorouracil Induction Therapy in Conversion to Curative Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma
ConclusionDCF and subsequent esophagectomy achieved R0 resection in 50% of the patients and was associated with better long-term oncological outcomes in patients with initially unresectable esophageal cancer if their systemic status is acceptable.
Source: World Journal of Surgery - Category: Surgery Source Type: research
More News: Borderline Tumor | Cancer | Cancer & Oncology | Carcinoma | Docetaxel | Esophagectomy | Esophagus Cancer | Skin Cancer | Squamous Cell Carcinoma | Study | Surgery | Taxotere